Multicenter Clinical Performance Evaluation of the NeuMoDx CT/NG Assay 2.0
Authors:
- Barbara Van Der PolBPBarbara Van Der Pol
- Ann AveryAAAnn Avery
- Stephanie N. TaylorSTStephanie N. Taylor
- Joseph MillerJMJoseph Miller
- Christopher L. EmeryCEChristopher L. Emery
- Alistair EnglishAEAlistair English
- Gweneth B. LazenbyGLGweneth B. Lazenby
- Rebecca LillisRLRebecca Lillis
- Jennifer RuthJRJennifer Ruth
- Douglas YoungDYDouglas Young
- Stephen YoungSYStephen Young
- Steven ChavoustieSCSteven Chavoustie
Open Access
- 4 December 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 52 (7) , 422-427
Abstract
Background: Given the continued increases in rates of both Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection, additional diagnostic assays may be useful in increasing access to testing for these sexually transmitted infections. We evaluated the performance of the NeuMoDx CT/NG Assay 2.0 on the NeuMoDx-96 and NeuMoDx-288 Molecular Systems. Methods: The clinical sensitivity and specificity of the assay were assessed when used with (1) endocervical swabs, (2) self- and clinician-collected vaginal swabs, and (3) first-catch urine specimens (female and male). Results were compared with a patient infection status based on US Food and Drug Administration–cleared assays. Results: The NeuMoDx CT/NG Assay 2.0 demonstrated high sensitivity and specificity in both symptomatic and asymptomatic participants. All specimen types other than endocervical swabs had ≥95% sensitivity and >99% specificity for both pathogens. For endocervical samples, sensitivities were 93.2% and 93.3% for CT and NG, respectively. There was no difference in performance based on platform. The frequency of invalid results was low (<1%). Conclusions: The NeuMoDx CT/NG Assay 2.0 demonstrated performance similar to currently US Food and Drug Administration–cleared assays, with the added choice of a moderate- (96-sample) or a high-throughput (288-sample) platform. The system therefore offers solutions to laboratories running lower volumes of testing that may obviate the need for outsourcing to larger reference laboratories.Keywords
This publication has 24 references indexed in Scilit:
- From the NIH: Proceedings of a Workshop on the Importance of Self-Obtained Vaginal Specimens for Detection of Sexually Transmitted InfectionsSexually Transmitted Diseases, 2008
- Acceptability of Self-Taken Vaginal Swabs and First-Catch Urine Samples for the Diagnosis of Urogenital Chlamydia trachomatis and Neisseria gonorrhoeae With an Amplified DNA Assay in Young Women Attending a Public Health Sexually Transmitted Disease ClinicSexually Transmitted Diseases, 2006
- Applications of Luminex® xMAP™ technology for rapid, high-throughput multiplexed nucleic acid detectionClinica Chimica Acta, 2006
- Women Find It Easy and Prefer to Collect Their Own Vaginal Swabs to Diagnose Chlamydia trachomatis or Neisseria gonorrhoeae InfectionsSexually Transmitted Diseases, 2005
- Use of Multiple Nucleic Acid Amplification Tests To Define the Infected-Patient “Gold Standard” in Clinical Trials of New Diagnostic Tests for Chlamydia trachomatis InfectionsJournal of Clinical Microbiology, 2004
- Comparison of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine SpecimensJournal of Clinical Microbiology, 2004
- Vaginal Swabs Are Appropriate Specimens for Diagnosis of Genital Tract Infection with Chlamydia trachomatisJournal of Clinical Microbiology, 2003
- Performance of the APTIMA Combo 2 Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Endocervical Swab SpecimensJournal of Clinical Microbiology, 2003
- Evaluation of a Modified Sanitary Napkin as a Sample Self-Collection Device for the Detection of Genital Chlamydial Infection in WomenJournal of Clinical Microbiology, 2001
- Multicenter Evaluation of the BDProbeTec ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral SwabsJournal of Clinical Microbiology, 2001